BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 1, 2026
See today's BioWorld Asia
Home
» Other news to note for Sept. 20, 2022
To read the full story,
subscribe
or
sign in
.
Other news to note for Sept. 20, 2022
Sep. 20, 2022
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Apollomics, Biocytogen, Biomarin, Cage, CSL, Enzolytics, Guangzhou Fineimmune, IDT Biologika, J Ints Bio, Merck, Metis, Peptistar, Qurient, Radiopharm, Rigimmune, Sorrento, Subintro, Tagcyx, Twist, Valeo, Valneva, Voronoi.
BioWorld Asia
Briefs
Other news to note